republic-os/legislation/us/states/de/151/sb-292.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO NALOXONE AND OTHER OPIOID ANTAGONISTS.	An opioid antagonist is a medication approved by the United States Food and Drug Administration (FDA) for emergency reversal of a known or suspected opioid overdose. Currently, naloxone is the only FDA-approved opioid antagonist, however, the FDA is expected to approve at least 1 new, more powerful opioid antagonist in 2022.	us/states/de	Delaware General Assembly	151	SB 292	Delaware SB 292 (151)	bill		enacted	Darius J. Brown David Bentz Sarah McBride Stephanie L. Hansen	2	9	2	2022-05-09	2022-11-02	openstates	ocd-bill/1842e8a7-a4f6-4e58-be25-84e3f4d0a461	https://legis.delaware.gov/BillDetail?LegislationId=109462	4ea1d83e540f0c028062d192b39c223ff9cb74cba67cc3b9fb69e2eb9760525d	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-de

Delaware SB 292 (151) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO NALOXONE AND OTHER OPIOID ANTAGONISTS.

An opioid antagonist is a medication approved by the United States Food and Drug Administration (FDA) for emergency reversal of a known or suspected opioid overdose. Currently, naloxone is the only FDA-approved opioid antagonist, however, the FDA is expected to approve at least 1 new, more powerful opioid antagonist in 2022.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Bill Text (committee substitute) — source
2. SA 1 to SB 292 (committee substitute) — source

Votes

• SM — 41–0 (pass) · lower
• SM — 18–0 (pass) · upper

Sponsors

• Darius J. Brown — primary (person)
• David Bentz — primary (person)
• Sarah McBride — primary (person)
• Stephanie L. Hansen — primary (person)
• Brian Pettyjohn — cosponsor (person)
• Bruce C. Ennis — cosponsor (person)
• Bryan Townsend — cosponsor (person)
• Bryant L. Richardson — cosponsor (person)
• Colin Bonini — cosponsor (person)
• Dave G. Lawson — cosponsor (person)
• David L. Wilson — cosponsor (person)
• David P. Sokola — cosponsor (person)
• Debra Heffernan — cosponsor (person)
• Eric Morrison — cosponsor (person)
• Ernesto B. Lopez — cosponsor (person)
• Gerald W. Hocker — cosponsor (person)
• John "Jack" Walsh — cosponsor (person)
• John A. Kowalko — cosponsor (person)
• Kendra Johnson — cosponsor (person)
• Kyle Evans Gay — cosponsor (person)
• Laura V. Sturgeon — cosponsor (person)
• Marie Pinkney — cosponsor (person)
• Michael F. Smith — cosponsor (person)
• Nicole Poore — cosponsor (person)
• Paul S. Baumbach — cosponsor (person)
• Ruth Briggs King — cosponsor (person)
• S. Elizabeth Lockman — cosponsor (person)
• Spiros Mantzavinos — cosponsor (person)
• Trey Paradee — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2022-05-09 Introduced and Assigned to Health & Social Services Committee in Senate introduction, referral-committee
• 2022-05-11 Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable, 1 On Its Merits committee-passage, committee-passage-favorable
• 2022-05-16 Amendment SA 1 to SB 292 - Introduced and Placed With Bill amendment-introduction
• 2022-05-17 Amendment SA 1 to SB 292 - Passed By Senate. Votes: 18 YES 3 ABSENT amendment-passage
• 2022-05-17 Passed By Senate. Votes: 18 YES 3 ABSENT passage
• 2022-05-18 Assigned to Health & Human Development Committee in House introduction, referral-committee
• 2022-06-15 Reported Out of Committee (Health & Human Development) in House with 4 Favorable, 4 On Its Merits committee-passage, committee-passage-favorable
• 2022-06-30 Passed By House. Votes: 41 YES passage
• 2022-11-02 Signed by Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1842e8a7-a4f6-4e58-be25-84e3f4d0a461. Confidence: reported (aggregated from official Delaware legislature records).